These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 7619670)

  • 1. Halofantrine pharmacokinetics in Kenyan children with non-severe and severe malaria.
    Watkins WM; Winstanley PA; Mberu EK; Kokwaro G; Murphy SA; Newton CJ; Mwangi I; Forster D; Marsh K
    Br J Clin Pharmacol; 1995 Mar; 39(3):283-7. PubMed ID: 7619670
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Population pharmacokinetics of halofantrine in healthy volunteers and patients with symptomatic falciparum malaria.
    Klein K; Aarons L; Ter Kuile FO; Nosten F; White NJ; Edstein MD; Teja-Isavadharm P
    J Pharm Pharmacol; 2012 Nov; 64(11):1603-13. PubMed ID: 23058047
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical efficacy and pharmacokinetics of micronized halofantrine for the treatment of acute uncomplicated falciparum malaria in nonimmune patients.
    Bouchaud O; Basco LK; Gillotin C; Gimenez F; Ramiliarisoa O; Genissel B; Bouvet E; Farinotti R; Le Bras J; Coulaud JP
    Am J Trop Med Hyg; 1994 Aug; 51(2):204-13. PubMed ID: 8074254
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of multiple-dose halofantrine in treatment of chloroquine-resistant falciparum malaria in children in Kenya.
    Watkins WM; Oloo JA; Lury JD; Mosoba M; Kariuki D; Mjomba M; Koech DK; Gilles HM
    Lancet; 1988 Jul; 2(8605):247-50. PubMed ID: 2899237
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of an extended-dose halofantrine regimen in patients with malaria and in healthy volunteers.
    Ohrt C; Watt G; Teja-Isavadharm P; Keeratithakul D; Loesuttiviboon L; Webster HK; Schuster B; Fleckenstein L
    Clin Pharmacol Ther; 1995 May; 57(5):525-32. PubMed ID: 7768075
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of halofantrine and n-desbutylhalofantrine in patients with falciparum malaria following a multiple dose regimen of halofantrine.
    Veenendaal JR; Parkinson AD; Kere N; Rieckmann KH; Edstein MD
    Eur J Clin Pharmacol; 1991; 41(2):161-4. PubMed ID: 1743249
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics, efficacy and toxicity of parenteral halofantrine in uncomplicated malaria.
    Krishna S; ter Kuile F; Supanaranond W; Pukrittayakamee S; Teja-Isavadharm P; Kyle D; White NJ
    Br J Clin Pharmacol; 1993 Dec; 36(6):585-91. PubMed ID: 12959277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of halofantrine in man: effects of food and dose size.
    Milton KA; Edwards G; Ward SA; Orme ML; Breckenridge AM
    Br J Clin Pharmacol; 1989 Jul; 28(1):71-7. PubMed ID: 2775616
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of micronized halofantrine in semi-immune patients with acute uncomplicated falciparum malaria in Cameroon.
    Fadat G; Louis FJ; Louis JP; Le Bras J
    Antimicrob Agents Chemother; 1993 Sep; 37(9):1955-7. PubMed ID: 8239611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of halofantrine in Thai patients with acute uncomplicated falciparum malaria.
    Karbwang J; Milton KA; Na Bangchang K; Ward SA; Edwards G; Bunnag D
    Br J Clin Pharmacol; 1991 Apr; 31(4):484-7. PubMed ID: 2049260
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Halofantrine in the treatment of acute malaria: a multi-centre study in 268 patients.
    Jagota SC
    Curr Med Res Opin; 1993; 13(3):140-4. PubMed ID: 8222741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Halofantrine treatment of uncomplicated falciparum malaria with high parasitaemia.
    Clerinx J; Taelman H
    Trans R Soc Trop Med Hyg; 1993; 87(1):80. PubMed ID: 8465406
    [No Abstract]   [Full Text] [Related]  

  • 13. Type RI resistance to halofantrine in West Africa.
    Basco LK; Le Bras J; Gillotin C; Ringwald P; Rabenjarson E; Gimenez F; Bouchaud O; Farinotti R; Coulaud JP
    Trop Med Parasitol; 1991 Dec; 42(4):413-4. PubMed ID: 1665577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Taste-masked quinine pamoate tablets for treatment of children with uncomplicated Plasmodium falciparum malaria.
    Kayitare E; Vervaet C; Mehuys E; Kayumba PC; Ntawukulilyayo JD; Karema C; Bortel V; Remon JP
    Int J Pharm; 2010 Jun; 392(1-2):29-34. PubMed ID: 20230885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The treatment of falciparum malaria in children with halofantrine suspension.
    Horton RJ; Parr SN; Bokor LC
    Mem Inst Oswaldo Cruz; 1992; 87 Suppl 3():265-9. PubMed ID: 1343699
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical pharmacokinetics of halofantrine.
    Karbwang J; Na Bangchang K
    Clin Pharmacokinet; 1994 Aug; 27(2):104-19. PubMed ID: 7955774
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Trial of halofantrine in the treatment of malaria attacks by Plasmodium falciparum in Dakar (Senegal)].
    Diallo S; Gaye O; Bah IB; Trape JF; Konate L; Legros C; Dieng T; Faye O
    Bull Soc Pathol Exot; 1991; 84(3):298-303. PubMed ID: 1764759
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Halofantrine: a new substance for treatment of multidrug-resistant malaria.
    Nothdurft HD; Clemens R; Bock HL; Löscher T
    Clin Investig; 1993 Jan; 71(1):69-73. PubMed ID: 8453264
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of prior administration of amodiaquine on the disposition of halofantrine in healthy volunteers.
    Omoruyi SI; Onyeji CO; Daniyan MO
    Ther Drug Monit; 2007 Apr; 29(2):203-6. PubMed ID: 17417075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Halofantrine in the treatment of uncomplicated falciparum malaria with a three-dose regimen in Papua New Guinea: a preliminary report.
    Hombhanje FW; Kereu RK; Bulungol P; Paika R
    P N G Med J; 1998 Mar; 41(1):23-9. PubMed ID: 10741174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.